Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study-Reference-Cited by-同舟云学术

Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study

Published:2018-07 Issue:4 Volume:12 Page:1008-1018.e1
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Anderson Jeffrey L.,Knowlton Kirk U.,May Heidi T.,Bair Tami L.,Armstrong Shannon O.,Lappé Donald L.,Muhlestein Joseph B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

3. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta analysis of individual data from 27 randomised trials;Mihaylova;Lancet,2012

4. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med,2008

5. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Active vs Passive Statin Selection for Primary Prevention;JACC: Advances;2023-12

2. Trends and determinants of prevalence, awareness, treatment and control of dyslipidaemia in canton of Geneva, 2005–2019: Potent statins are underused;International Journal of Cardiology Cardiovascular Risk and Prevention;2023-09

3. Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients;Circulation: Cardiovascular Quality and Outcomes;2023-08

4. Statin use improves survival of patients with known or suspected lower extremity artery disease on all ankle brachial index levels;Vasa;2023-01

5. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.;Journal of the American College of Cardiology;2022-05